Cargando…
Retinoprotective compounds, current efficacy, and future prospective
Retinal dysfunction is the most common cause of vision loss in several retinal disorders. It has been estimated a great increase in these pathologies that are becoming more globally widespread and numerous over time, also supported by the life expectancy increment. Among different types of retinopat...
Autores principales: | Marino, Rachele, Sappington, Rebecca, Feligioni, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358657/ https://www.ncbi.nlm.nih.gov/pubmed/37449599 http://dx.doi.org/10.4103/1673-5374.373662 |
Ejemplares similares
-
The retinoprotective role of phenytoin
por: Bartollino, Silvia, et al.
Publicado: (2018) -
Delivery Systems of Retinoprotective Proteins in the Retina
por: Rebustini, Ivan T., et al.
Publicado: (2021) -
Cell-based assays to identify novel retinoprotective agents
por: Bullock, Jeanee, et al.
Publicado: (2020) -
Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
por: Keppel Hesselink, Jan M., et al.
Publicado: (2015) -
Retinoprotective Effect of 2-Ethyl-3-hydroxy-6-methylpyridine Nicotinate
por: Peresypkina, Anna, et al.
Publicado: (2020)